Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer

Ivan Storgaard Vogelius; David C Westerly; Marianne C Aznar; George M Cannon; Stine S Korreman; Thomas R Mackie; Minesh P Mehta; Søren M Bentzen

doi:10.3109/0284186X.2011.582519

Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer

Ivan Storgaard Vogelius, David C Westerly, Marianne C Aznar, George M Cannon, Stine S Korreman, Thomas R Mackie, Minesh P Mehta, Søren M Bentzen

25 Citations (Scopus)

Abstract

Traditionally, radiation therapy plans are optimized without consideration of chemotherapy. Here, we model the risk of radiation pneumonitis (RP) in the presence of a possible interaction between chemotherapy and radiation dose distribution.

Original language	English
Journal	Acta Oncologica
Volume	50
Issue number	6
Pages (from-to)	772-6
Number of pages	5
ISSN	0284-186X
DOIs	https://doi.org/10.3109/0284186X.2011.582519
Publication status	Published - 2011

Keywords

Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Chemoradiotherapy
Humans
Lung Neoplasms
Monte Carlo Method
Photons
Protons
Radiation Pneumonitis
Risk Factors
Treatment Outcome

Access to Document

10.3109/0284186X.2011.582519

Cite this

@article{40b63a171d2a4fec870f68d72846c067,

title = "Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer",

abstract = "Traditionally, radiation therapy plans are optimized without consideration of chemotherapy. Here, we model the risk of radiation pneumonitis (RP) in the presence of a possible interaction between chemotherapy and radiation dose distribution.",

keywords = "Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy, Humans, Lung Neoplasms, Monte Carlo Method, Photons, Protons, Radiation Pneumonitis, Risk Factors, Treatment Outcome",

author = "Vogelius, {Ivan Storgaard} and Westerly, {David C} and Aznar, {Marianne C} and Cannon, {George M} and Korreman, {Stine S} and Mackie, {Thomas R} and Mehta, {Minesh P} and Bentzen, {S{\o}ren M}",

year = "2011",

doi = "10.3109/0284186X.2011.582519",

language = "English",

volume = "50",

pages = "772--6",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Informa Healthcare",

number = "6",

}

TY - JOUR

T1 - Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer

AU - Vogelius, Ivan Storgaard

AU - Westerly, David C

AU - Aznar, Marianne C

AU - Cannon, George M

AU - Korreman, Stine S

AU - Mackie, Thomas R

AU - Mehta, Minesh P

AU - Bentzen, Søren M

PY - 2011

Y1 - 2011

N2 - Traditionally, radiation therapy plans are optimized without consideration of chemotherapy. Here, we model the risk of radiation pneumonitis (RP) in the presence of a possible interaction between chemotherapy and radiation dose distribution.

AB - Traditionally, radiation therapy plans are optimized without consideration of chemotherapy. Here, we model the risk of radiation pneumonitis (RP) in the presence of a possible interaction between chemotherapy and radiation dose distribution.

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Carcinoma, Non-Small-Cell Lung

KW - Chemoradiotherapy

KW - Humans

KW - Lung Neoplasms

KW - Monte Carlo Method

KW - Photons

KW - Protons

KW - Radiation Pneumonitis

KW - Risk Factors

KW - Treatment Outcome

U2 - 10.3109/0284186X.2011.582519

DO - 10.3109/0284186X.2011.582519

M3 - Journal article

C2 - 21767173

SN - 0284-186X

VL - 50

SP - 772

EP - 776

JO - Acta Oncologica

JF - Acta Oncologica

IS - 6

ER -

Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer

Abstract

Keywords

Access to Document

Fingerprint

Cite this